PUBLISHER: The Business Research Company | PRODUCT CODE: 1669613
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669613
Farm animal drugs are critical medications developed for the treatment, prevention, and management of diseases in livestock, including cattle, pigs, and poultry. These medications play a vital role in ensuring animal health, enhancing productivity, and controlling the spread of infections. By promoting the well-being of livestock, farm animal drugs are essential for maintaining food safety and adhering to veterinary health standards in agricultural operations. Their use is crucial in supporting sustainable farming practices and ensuring a stable food supply.
The primary categories of farm animal drugs include anti-infective, parasiticides, anti-inflammatory agents, anesthetics, analgesics, hormones, and related products, among others. Anti-infective drugs are specifically designed to combat infections, either by preventing the spread of infectious agents or by eradicating the pathogen causing the infection. These medications are valuable in treating severe infections in various animals, including equine and small animals. Administration routes for farm animal drugs include oral, parenteral, topical, and other methods. These drugs are distributed through channels such as veterinary hospitals, veterinary clinics, pharmacies, drug stores, and other outlets, catering to diverse animals, including livestock and equine species.
The farm animal drugs research report is one of a series of new reports from The Business Research Company that provides farm animal drugs market statistics, including the farm animal drugs industry's global market size, regional shares, competitors with farm animal drugs market share, detailed farm animal drugs market segments, market trends and opportunities, and any further data you may need to thrive in the farm animal drugs industry. This farm animal drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The farm animal drugs market size has grown strongly in recent years. It will grow from $19.41 billion in 2024 to $20.71 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to increasing consumer demand for animal products, rise in zoonotic diseases, disease prevention and control, intensification of livestock farming, global population growth
The farm animal drugs market size is expected to see strong growth in the next few years. It will grow to $26.85 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising awareness of antimicrobial resistance, climate change impacts on livestock health, increasing focus on animal nutrition, rise in alternative proteins, phytogenic feed additives, biopharmaceuticals for livestock, digital platforms for farm animal health management. Major trends in the forecast period include technological advancements in veterinary medicine, advancements in precision livestock farming technologies, blockchain technology for supply chain transparency, integration of AI and ML.
The anticipated growth in the farm animal drug market is expected to be propelled by the increasing consumption of meat. Meat consumption, which involves consuming animal flesh as a food source, is commonly derived from livestock such as chickens, pigs, or cattle. Farm animal drugs play a role in accelerating animal development and enhancing the transformation of food into meat. Therefore, the rising trend in meat consumption is likely to contribute to the increased demand for farm animal drugs. For example, in April 2023, as reported by the United States Department of Agriculture (USDA), beef meat consumption rose from 12,712 metric tons in 2021 to 12,803 metric tons in 2022. Pork meat consumption also increased from 9,918 metric tons in 2021 to 9,959 metric tons in 2022, while chicken meat consumption saw an increase from 17,164 metric tons in 2021 to 17,674 metric tons in 2022. Consequently, the surge in meat consumption is a driving factor for the farm animal drug market.
The increase in zoonotic diseases is anticipated to drive the growth of the farm animal drugs market. Zoonotic diseases are infectious conditions caused by pathogens that can spread between animals and humans. Farm animal drugs are essential in managing these diseases by preventing and treating infections that can be transmitted between animals and humans. For example, in December 2023, according to the European Food Safety Authority, an Italy-based government agency, and the European Centre for Disease Prevention and Control, a Sweden-based government agency, campylobacteriosis and salmonellosis were the most frequently reported zoonotic diseases in humans in 2022, ranking first and second, respectively. Additionally, there was an increase of over 600% in locally acquired cases of human West Nile virus infection in 2022 compared to 2021. Therefore, the rise in zoonotic diseases is a significant driver of the farm animal drugs market.
Leading firms in the farm animal drugs sector are concentrating on the development of antimicrobial drugs, specifically water-soluble granules, aimed at enhancing their competitive position. Water-soluble granules, characterized as solid, easily dissolvable particles in water, find utility in the precise dispersion of substances across various applications. For instance, in October 2023, Pharmgate Animal Health, a US-based livestock pharmaceutical company, secured FDA approval for Aivlosin Water Soluble Granules (WSG), containing 62.5% w/w tylvalosin as tylvalosin tartrate for female swine designated for breeding. This approval permits its use in replacement gilts, gestating sows, lactating sows, and weaned sows. Aivlosin, an antimicrobial drug, is prescribed by licensed veterinarians and is continuously administered at 50 ppm tylvalosin in drinking water for five consecutive days. The approval extends its application to controlling porcine proliferative enteropathy and swine respiratory disease in breeding females during outbreaks.
Prominent entities in the farm animal drugs market are actively engaged in devising inventive solutions, such as moxidectin injectable solutions, designed for effective cattle parasite control with the aim of maximizing market profitability. Moxidectin injectable solution, an antiparasitic drug in liquid form, is employed for treating and managing internal and external parasites in cattle. For example, in March 2023, Norbrook Laboratories Ltd., a UK-based pharmaceutical company, obtained FDA approval for Tauramox, the inaugural generic moxidectin injectable solution intended for the treatment and control of internal and external parasites in beef and nonlactating dairy cattle. Tauramox matches the concentration of moxidectin and is available over the counter in 10 mg/ml concentration, packaged in 250-ml and 500-mL bottles, with a recommended administration rate of 1 mL per 110 lb body weight.
In March 2022, SeQuent Scientific Limited, an India-based manufacturer specializing in active pharmaceutical ingredients, animal health products, and specialty chemicals, completed the acquisition of Nourrie Saude e Nutricao Animal Ltda. for $5 million through its wholly-owned subsidiary, Alivira Animal Health Limited. This acquisition facilitated Alivira Animal Health Limited's expansion in Brazil by incorporating nutraceutical therapeutic products and Transuin, a ractopamine-based swine product currently manufactured by Nourrie. Nourrie Saude e Nutricao Animal Ltda., based in Brazil, is dedicated to developing therapeutics and supplements for animal health.
Major companies operating in the farm animal drugs market include Eli Lilly and Company, Boehringer Ingelheim GmbH, Zoetis Inc., Elanco Animal Health Incorporated, Hester Biosciences Limited, Ceva Sante Animale SA, Virbac SA, Huvepharma Inc, Phibro Animal Health Corporation, Dechra Pharmaceuticals plc, Laboratorios Hipra S.A., Norbrook Laboratories Ltd., Neogen Corporation, Ouro Fino Saude Animal Participacoes SA, Eco Animal Health Ltd, Biogenesis Bago SA, Laboratorios Calier S.A., Laboratorios Syva S.A., Jurox Pty Ltd, Kepro B.V., Kyoritsu Seiyaku Corp., Merck Animal Health, Vetoquinol SA, Nippon Zenyaku Kogyo Co. Ltd., SeQuent Scientific Limited, Agrovet Market Animal Health, Orion Pharma Animal Health, Zydus Animal Health and Investments Limited
Asia-Pacific was the largest region in the farm animal drugs market in 2024. The regions covered in the farm animal drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the farm animal drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The farm animal drugs market consists of sales of endo-parasiticides, ectoparasitic ides, and endectocides. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Farm Animal Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on farm animal drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for farm animal drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The farm animal drugs market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Subsegments